DAVID GRANOVSKY

Cellular Dynamics’ stem cells named to top 10 emerging technologies list – JSOnline

In BUSINESS OF STEM CELLS on April 21, 2010 at 5:07 pm

A few things of note:
1.  This article is about James Thomson putting his money where his mouth is…into non-embryonic stem cell research.  Long ago, he jumped off the embryonic stem cell research “ship” and into other stem cell research.  This is fairly significant because he is the one who built that ship from the ground up!  (
James Alexander Thomson is an American developmental biologist who is best known for deriving the first human embryonic stem cell line.)

2.  This article is about induced pluripotent stem cells: “The stem cells (Cellular Dynamics) CDI sells aren’t made from human embryos. CDI scientists take tissue cells, for example, and engineer them to make cells that have the characteristics of embryonic stem cells and are able to turn into beating heart cells, liver cells or other cells in the body.”  Further of note, adult or repair stem cells are already “able to turn into beating heart cells, liver cells or other cells in the body and have been for years.”

3.  Those guys over at MIT Technology Review are pretty smart.  They know the future is NOT in embryonic stem cell research…just as James does…or more importantly, they know that embryonic stem cells are NOT one of the “top 10 emerging technologies.”  Otherwise, something with embryonic stem cells would have made the list.  Or maybe Geron would have with their embryonic clinical trial that has been put on hold 11 times now…what?  It’s 12 or 13? Sorry, I can’t keep track anymore.

Read on…

Cellular Dynamics’ stem cells named to

top 10 emerging technologies list

By Kathleen Gallagher of the Journal Sentinel

Posted: April 21, 2010 11:54 a.m. |(2) Comments

James Thomson’s engineered stem cells have joined green concrete, mobile 3-D content and other innovations on the MIT Technology Review’s annual list of its top 10 emerging technologies.

Stem cell pioneer Thomson and his company, Cellular Dynamics, have potentially revolutionized the way disease is studied and potential drugs are screened for toxicity, the editors of the publication said.

The privately held company, known as CDI, has a proprietary process to manufacture large quantities of human tissue cells that companies use for research and to screen drugs.

“Stem cell technology has significant potential to improve human health,” Thomson said in a news release issued by his company.

The stem cells CDI sells aren’t made from human embryos. CDI scientists take tissue cells, for example, and engineer them to make cells that have the characteristics of embryonic stem cells and are able to turn into beating heart cells, liver cells or other cells in the body.

via Cellular Dynamics’ stem cells named to top 10 emerging technologies list – JSOnline.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: